化学蛋白质学将RBBP7确定为一种新的E3酶,支持向蛋白质降解
Yue Liu1,2,3, Tao Yang1,2,3, Lei Huang1,2,3
1State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, 601 Huangpu Avenue West, Guangzhou, 510632, China.
Angewandte Chemie (International ed. in English)
|July 2, 2025
概括
新型基于 ynamide 的降解剂克服了针对蛋白质降解的 E3 酶限制. 这些化合物显示出增强的抗癌功效和广泛适用于各种疾病点.
科学领域:
- 药用化学 医学化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 向蛋白质降解 (TPD) 是一个有前途的治疗策略.
- 现有的TPD方法由于依赖于少数E3无处不在链酶 (例如CRBN,VHL) 而受到限制.
- 需要新的降解剂,具有更广泛的E3酶参与.
研究的目的:
- 开发新的小分子降解剂,克服E3酶的局限性.
- 为了研究由含有 ynamide 的化合物介导的降解机制.
- 评估这些新型降解剂的治疗潜力,特别是在癌症中.
主要方法:
- 一个 ynamide 电的集成到各种针对蛋白质的配体中.
- 使用蛋白质组概况评估目标降解能力的评估.
- 协价接触分析和降解机制的功能验证.
主要成果:
- 新型基于khaminide的降解剂证明了强大的目标降解.
- ynamide 基因对 RBBP7 E3 酶的 Cys97 残留物进行了共价的接触.
- 胺降解剂显示出增强的抗癌功效和广泛适用于包括酶和突变EGFR在内的各种标.
结论:
- 亚纳米德电友代表了开发新型降解剂的多功能化学处理器.
- 这种方法克服了现有的E3酶依赖降解剂的局限性.
- 含伊纳米德的降解剂为增强癌症治疗提供了一个有希望的策略.
相关概念视频
Regulated Protein Degradation
7.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.7K
The Proteasome
1.2K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.2K
Export of Misfolded Proteins out of the ER
3.9K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.9K


